SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-009145 to WESTLAKE CORP (WLK) (CIK 0001262823) (WLK)

WESTLAKE CORP (WLK) (CIK 0001262823)
Date: Aug. 9, 2024 · CIK: 0001262823 · Accession: 0000000000-24-009145

AI Filing Summary & Sentiment

File numbers found in text: 001-32260

Date
August 9, 2024
Author
Not clearly detected
Form
UPLOAD
Company
WESTLAKE CORP (WLK) (CIK 0001262823)

Letter

August 9, 2024 Jean-Marc Gilson President and Chief Executive Officer Westlake Corporation 2801 Post Oak Boulevard, Suite 600 Houston, TX 77056 Re:Westlake Corporation Definitive Proxy Statement on Schedule 14A Filed March 29, 2024 File No. 001-32260 Dear Jean-Marc Gilson: We have limited our review of your most recent definitive proxy statement to those issues we have addressed in our comment(s). Please respond to this letter by providing the requested information and/or confirming that you will revise your future proxy disclosures in accordance with the topics discussed below. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments. Definitive Proxy Statement on Schedule 14A Pay-Versus-Performance Compensation Table, page 31 The tables you have provided pursuant to Item 402(v) of Regulation S-K include several numerical amounts we are unable to confirm using the data in the Summary Compensation Table on page 23. For example, the amounts listed for 2021 and 2022 in the column titled “Summary Compensation Table Total for CEO($)” are not the same as the amounts listed in the total column of the Summary Compensation Table. Similarly, we are unable to confirm the 2023 average included under the pay versus performance table column titled “Avg. Summary Compensation Table Total for Non-CEO NEOs($)” using the 2023 Summary Compensation Table totals for Messrs. James Chao, Bender, Buesinger and Ederington. In addition, the amounts you have included in footnote 2 in the row titled “Deduction for amounts reported under the ‘Stock Awards’ column in the Summary Compensation Table” do not appear in the Summary Compensation Table. Please provide us additional information about the reasons for these discrepancies or 1.

August 9, 2024 Page 2 confirm that you will address them in future proxy filings. 2.It appears that you have included net income attributable to Westlake Corporation in your pay versus performance table in lieu of net income as required by Item 402(v)(2)(v) of Regulation S-K. Please include net income (loss), as reported in your audited GAAP financial statements, in your pay versus performance table and related disclosure for all years covered by the table. Refer to Regulation S-K Compliance and Disclosure Interpretation 128D.08. Please note that you may voluntarily provide supplemental measures of net income or financial performance, so long as any additional disclosure is “clearly identified as supplemental, not misleading, and not presented with greater prominence than the required disclosure.” See Pay Versus Performance, Release No. 34- 95607 (August 25, 2022) [87 FR 55134 (September 8, 2022)] at Section II.F.3. 3.We note that you have included “Economic Value Added,” a non-GAAP measure, as your Company-Selected Measure pursuant to Item 402(v)(2)(vi) of Regulation S-K. It is not clear from your disclosure on page 32 how this number is calculated from your audited financial statements. Please provide further discussion of where you derive the “Weighted Average Cost of Capital” from your audited financial statements, including all adjustments made to this metric. Please also provide clarity on “certain amortization expenses” and “other items as deemed appropriate by the Committee” and how these are derived from your audited financial statements. Note that incorporation by reference to disclosure in a separate filing will not satisfy this disclosure requirement. 4.We note disclosure in footnote 5 to your pay versus performance table that the compensation actually paid amounts for 2021 and 2022 were revised to correct an error in the calculation of the fair value of option awards. We also note that you limited your footnote disclosure to the most recent fiscal year. Regulation S-K Compliance and Disclosure Interpretation 128D.03 contemplates omitting footnote disclosure for all years other than the most recent fiscal year unless the prior years’ footnote disclosure would be material to an investor’s understanding of the information reported in the pay versus performance table for the most recent fiscal year, or of the relationship disclosure provided under Item 402(v)(5) of Regulation S-K. Please tell us how you concluded that you were not required to provide footnote disclosure for years other than the most recent fiscal year in light of the revisions to your compensation actually paid amounts for 2021 and 2022. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Charlotte Young at 202-551-3280 or Amanda Ravitz at 202-551-3412 with any questions. Sincerely, Division of Corporation Finance Disclosure Review Program

Show Raw Text
August 9, 2024
Jean-Marc Gilson
President and Chief Executive Officer
Westlake Corporation
2801 Post Oak Boulevard, Suite 600
Houston, TX 77056
Re:Westlake Corporation
Definitive Proxy Statement on Schedule 14A
Filed March 29, 2024
File No. 001-32260
Dear Jean-Marc Gilson:
            We have limited our review of your most recent definitive proxy statement to those issues
we have addressed in our comment(s).
            Please respond to this letter by providing the requested information and/or confirming that
you will revise your future proxy disclosures in accordance with the topics discussed below. If
you do not believe a comment applies to your facts and circumstances, please tell us why in your
response.
            After reviewing your response to this letter, we may have additional comments.
Definitive Proxy Statement on Schedule 14A
Pay-Versus-Performance Compensation Table, page 31
The tables you have provided pursuant to Item 402(v) of Regulation S-K include several
numerical amounts we are unable to confirm using the data in the Summary
Compensation Table on page 23. For example, the amounts listed for 2021 and 2022 in
the column titled “Summary Compensation Table Total for CEO($)” are not the same as
the amounts listed in the total column of the Summary Compensation Table. Similarly, we
are unable to confirm the 2023 average included under the pay versus performance table
column titled “Avg. Summary Compensation Table Total for Non-CEO NEOs($)” using
the 2023 Summary Compensation Table totals for Messrs. James Chao, Bender,
Buesinger and Ederington. In addition, the amounts you have included in footnote 2 in the
row titled “Deduction for amounts reported under the ‘Stock Awards’ column in the
Summary Compensation Table” do not appear in the Summary Compensation Table.
Please provide us additional information about the reasons for these discrepancies or 1.

August 9, 2024
Page 2
confirm that you will address them in future proxy filings.
2.It appears that you have included net income attributable to Westlake Corporation in your
pay versus performance table in lieu of net income as required by Item 402(v)(2)(v) of
Regulation S-K. Please include net income (loss), as reported in your audited GAAP
financial statements, in your pay versus performance table and related disclosure for all
years covered by the table. Refer to Regulation S-K Compliance and Disclosure
Interpretation 128D.08. Please note that you may voluntarily provide supplemental
measures of net income or financial performance, so long as any additional disclosure is
“clearly identified as supplemental, not misleading, and not presented with greater
prominence than the required disclosure.” See Pay Versus Performance, Release No. 34-
95607 (August 25, 2022) [87 FR 55134 (September 8, 2022)] at Section II.F.3.
3.We note that you have included “Economic Value Added,” a non-GAAP measure, as your
Company-Selected Measure pursuant to Item 402(v)(2)(vi) of Regulation S-K. It is not
clear from your disclosure on page 32 how this number is calculated from your audited
financial statements. Please provide further discussion of where you derive the “Weighted
Average Cost of Capital” from your audited financial statements, including all
adjustments made to this metric. Please also provide clarity on “certain amortization
expenses” and “other items as deemed appropriate by the Committee” and how these are
derived from your audited financial statements. Note that incorporation by reference to
disclosure in a separate filing will not satisfy this disclosure requirement.
4.We note disclosure in footnote 5 to your pay versus performance table that the
compensation actually paid amounts for 2021 and 2022 were revised to correct an error in
the calculation of the fair value of option awards. We also note that you limited your
footnote disclosure to the most recent fiscal year. Regulation S-K Compliance and
Disclosure Interpretation 128D.03 contemplates omitting footnote disclosure for all years
other than the most recent fiscal year unless the prior years’ footnote disclosure would be
material to an investor’s understanding of the information reported in the pay versus
performance table for the most recent fiscal year, or of the relationship disclosure
provided under Item 402(v)(5) of Regulation S-K. Please tell us how you concluded that
you were not required to provide footnote disclosure for years other than the most recent
fiscal year in light of the revisions to your compensation actually paid amounts for 2021
and 2022.
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
            Please contact Charlotte Young at 202-551-3280 or Amanda Ravitz at 202-551-3412 with
any questions.
Sincerely,
Division of Corporation Finance
Disclosure Review Program